D. Cristopher Bragg

991 total citations
23 papers, 515 citations indexed

About

D. Cristopher Bragg is a scholar working on Neurology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, D. Cristopher Bragg has authored 23 papers receiving a total of 515 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Neurology, 10 papers in Cellular and Molecular Neuroscience and 7 papers in Neurology. Recurrent topics in D. Cristopher Bragg's work include Neurological disorders and treatments (14 papers), Genetic Neurodegenerative Diseases (10 papers) and Parkinson's Disease Mechanisms and Treatments (6 papers). D. Cristopher Bragg is often cited by papers focused on Neurological disorders and treatments (14 papers), Genetic Neurodegenerative Diseases (10 papers) and Parkinson's Disease Mechanisms and Treatments (6 papers). D. Cristopher Bragg collaborates with scholars based in United States, Philippines and United Kingdom. D. Cristopher Bragg's co-authors include Xandra O. Breakefield, Nutan Sharma, Mark G. Baxter, Brian Niland, Jeremy Petravicz, David G. Standaert, Juan Zeng, Jeffrey Hewett, Laurie J. Ozelius and Flávia C. Nery and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Neuroscience and The Lancet Neurology.

In The Last Decade

D. Cristopher Bragg

22 papers receiving 510 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Cristopher Bragg United States 12 347 333 122 69 50 23 515
Ji‐Yoen Kim United States 9 85 0.2× 153 0.5× 288 2.4× 57 0.8× 38 0.8× 9 508
Ina Zorn Netherlands 8 239 0.7× 678 2.0× 180 1.5× 264 3.8× 154 3.1× 9 776
Maila Giannandrea Italy 8 126 0.4× 129 0.4× 164 1.3× 19 0.3× 132 2.6× 8 384
Kinga Bercsényi United Kingdom 8 187 0.5× 272 0.8× 148 1.2× 39 0.6× 51 1.0× 8 460
Zoe Siemienski United States 8 119 0.3× 100 0.3× 214 1.8× 88 1.3× 27 0.5× 9 390
Ewa Bomba-Warczak United States 10 65 0.2× 135 0.4× 175 1.4× 44 0.6× 111 2.2× 13 399
Luís Quintino Sweden 10 63 0.2× 116 0.3× 144 1.2× 57 0.8× 20 0.4× 17 307
Holger Haselmann Germany 10 365 1.1× 173 0.5× 118 1.0× 54 0.8× 75 1.5× 12 502
Melissa A. Hayes United States 5 198 0.6× 145 0.4× 143 1.2× 40 0.6× 114 2.3× 7 406
Pedro José Tomaselli Brazil 11 102 0.3× 256 0.8× 160 1.3× 87 1.3× 56 1.1× 35 382

Countries citing papers authored by D. Cristopher Bragg

Since Specialization
Citations

This map shows the geographic impact of D. Cristopher Bragg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Cristopher Bragg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Cristopher Bragg more than expected).

Fields of papers citing papers by D. Cristopher Bragg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Cristopher Bragg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Cristopher Bragg. The network helps show where D. Cristopher Bragg may publish in the future.

Co-authorship network of co-authors of D. Cristopher Bragg

This figure shows the co-authorship network connecting the top 25 collaborators of D. Cristopher Bragg. A scholar is included among the top collaborators of D. Cristopher Bragg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Cristopher Bragg. D. Cristopher Bragg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sharma, Nutan, Edwina Abou Haidar, Tianhe Xiao, et al.. (2025). Non-invasive detection of allele-specific CRISPR-SaCas9-KKH disruption of TOR1A DYT1 allele in a xenograft mouse model. Molecular Therapy — Nucleic Acids. 36(1). 102466–102466.
2.
Rosenkrantz, Jimi L., et al.. (2024). ZNF91 is an endogenous repressor of the molecular phenotype associated with X-linked dystonia–parkinsonism (XDP). Proceedings of the National Academy of Sciences. 121(33). e2401217121–e2401217121. 1 indexed citations
3.
Petrozziello, Tiziana, Dan Lei, Ellen B. Penney, et al.. (2024). Targeting Myeloperoxidase to Reduce Neuroinflammation in X‐Linked Dystonia Parkinsonism. CNS Neuroscience & Therapeutics. 30(11). e70109–e70109. 2 indexed citations
4.
Vegezzi, Elisa, D. Cristopher Bragg, David Pellerin, et al.. (2024). Neurological disorders caused by novel non-coding repeat expansions: clinical features and differential diagnosis. The Lancet Neurology. 23(7). 725–739. 5 indexed citations
5.
Vaine, Christine A., Wataru Obuchi, Shadi Mahjoum, et al.. (2023). Tracking human neurologic disease status in mouse brain/plasma using reporter-tagged, EV-associated biomarkers. Molecular Therapy. 31(7). 2206–2219. 5 indexed citations
6.
Tshilenge, Kizito‐Tshitoko, Joanna Bons, Cristian Gerónimo‐Olvera, et al.. (2023). Proteomic analysis of X-linked dystonia parkinsonism disease striatal neurons reveals altered RNA metabolism and splicing. Neurobiology of Disease. 190. 106367–106367. 4 indexed citations
7.
D’Ignazio, Laura, Taylor A. Evans, Kenneth E. Diffenderfer, et al.. (2022). Variation in TAF1 Expression in Female Carrier-Induced Pluripotent Stem Cells and Human Brain Ontogeny Has Implications for Adult Neostriatum Vulnerability in X-Linked Dystonia Parkinsonism. eNeuro. 9(4). ENEURO.0129–22.2022. 1 indexed citations
8.
Domingo, Aloysius, Rachita Yadav, William T. Hendriks, et al.. (2021). Dystonia-specific mutations in THAP1 alter transcription of genes associated with neurodevelopment and myelin. The American Journal of Human Genetics. 108(11). 2145–2158. 14 indexed citations
9.
Petrozziello, Tiziana, Christine A. Vaine, Ellen B. Penney, et al.. (2020). Neuroinflammation and histone H3 citrullination are increased in X-linked Dystonia Parkinsonism post-mortem prefrontal cortex. Neurobiology of Disease. 144. 105032–105032. 17 indexed citations
10.
Cruz, Lilian, Bence György, Pike-See Cheah, et al.. (2020). Mutant Allele-Specific CRISPR Disruption in DYT1 Dystonia Fibroblasts Restores Cell Function. Molecular Therapy — Nucleic Acids. 21. 1–12. 10 indexed citations
11.
Bragg, D. Cristopher, Nutan Sharma, & Laurie J. Ozelius. (2019). X-Linked Dystonia-Parkinsonism: recent advances. Current Opinion in Neurology. 32(4). 604–609. 17 indexed citations
12.
Vaine, Christine A., David Shin, Christina Liu, et al.. (2016). X-linked Dystonia-Parkinsonism patient cells exhibit altered signaling via nuclear factor-kappa B. Neurobiology of Disease. 100. 108–118. 8 indexed citations
13.
Bragg, D. Cristopher & Nutan Sharma. (2014). Update on Treatments for Dystonia. Current Neurology and Neuroscience Reports. 14(6). 454–454. 4 indexed citations
14.
Gavarini, Sophie, et al.. (2011). Dimerization of the DYT6 dystonia protein, THAP1, requires residues within the coiled‐coil domain. Journal of Neurochemistry. 118(6). 1087–1100. 26 indexed citations
15.
Bragg, D. Cristopher, et al.. (2010). Molecular pathways in dystonia. Neurobiology of Disease. 42(2). 136–147. 63 indexed citations
16.
Hewett, Jeffrey, Juan Zeng, Brian Niland, D. Cristopher Bragg, & Xandra O. Breakefield. (2005). Dystonia-causing mutant torsinA inhibits cell adhesion and neurite extension through interference with cytoskeletal dynamics. Neurobiology of Disease. 22(1). 98–111. 81 indexed citations
17.
Meeker, Rick B., et al.. (2004). Development of Neuronal Sensitivity to Toxins in Cerebrospinal Fluid from HIV-Type 1-Infected Individuals. AIDS Research and Human Retroviruses. 20(10). 1072–1086. 7 indexed citations
18.
Bragg, D. Cristopher, Sara M. Camp, Jeremy Wilbur, et al.. (2004). Perinuclear biogenesis of mutant torsin-a inclusions in cultured cells infected with tetracycline-regulated herpes simplex virus type 1 amplicon vectors. Neuroscience. 125(3). 651–661. 41 indexed citations
19.
Bragg, D. Cristopher, et al.. (2002). Infection of the choroid plexus by feline immunodeficiency virus. Journal of NeuroVirology. 8(3). 211–224. 25 indexed citations
20.
Bragg, D. Cristopher, et al.. (2002). Choroid plexus macrophages proliferate and release toxic factors in response to feline immunodeficiency virus. Journal of NeuroVirology. 8(3). 225–239. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ji‐Yoen Kim Breakdown of academic impact, for papers by Ina Zorn Breakdown of academic impact, for papers by Maila Giannandrea Breakdown of academic impact, for papers by Kinga Bercsényi Breakdown of academic impact, for papers by Zoe Siemienski Breakdown of academic impact, for papers by Ewa Bomba-Warczak Breakdown of academic impact, for papers by Luís Quintino Breakdown of academic impact, for papers by Holger Haselmann Breakdown of academic impact, for papers by Melissa A. Hayes Breakdown of academic impact, for papers by Pedro José Tomaselli
Rankless by CCL
2026